There are currently 1290 clinical trials in Miami, Florida looking for participants to engage in research studies. Trials are conducted at various facilities, including University of Miami, GSK Investigational Site, University of Miami Miller School of Medicine-Sylvester Cancer Center and University of Miami Miller School of Medicine. Whether you're a healthy volunteer looking to participate in paid medical research or seeking trials related to a specific condition, the city provides a diverse range of opportunities near you.
Physical Activity in Hidradenitis Suppurativa (HS)
NCT06015438
Recruiting
The purpose of the study is to characterize the challenges to physical activity and exercise for HS patients and design an exercise program (EP) with evidence-based techniques and examine its outcome.
Gender:
All
Ages:
Between 18 years and 80 years
Trial Updated:
10/19/2023
Locations: University of Miami, Miami, Florida
Conditions: Hidradenitis Suppurativa
Register for Updates
Spinal COrd NeuromodulaTor by SpIneX and ScoNE to Treat NeurogeniC BladdEr - SCONE "CONTINENCE" Clinical Study
NCT05301335
Recruiting
The purpose of this study is to evaluate the effectiveness and safety of SCONE neuromodulation therapy after 12 weeks of therapy in comparison to inactive sham control in improving symptoms of Neurogenic Lower Urinary Tract Dysfunction
Gender:
All
Ages:
Between 18 years and 75 years
Trial Updated:
10/19/2023
Locations: University of Miami, Desai Sehti Urology Institute, Miami, Florida
Conditions: Neurogenic Bladder, Stroke, Multiple Sclerosis, Spinal Cord Injuries (Complete and Incomplete)
Register for Updates
Tigulixostat, Phase 3 Study, Allopurinol Controlled in Gout Patients
NCT05586971
Recruiting
The aim of this 12-month randomized multi-regional double-blind parallel group allopurinol and placebo-controlled phase 3 study is to assess the efficacy and safety of three different doses of Tigulixostat in gout patients with hyperuricemia.
Gender:
All
Ages:
Between 18 years and 85 years
Trial Updated:
10/17/2023
Locations: Homestead Associates in Research,Inc, Miami, Florida +8 locations
Conditions: Gout, Hyperuricemia, Gout Flare, Tophi
Register for Updates
Mental Health in Primary Care
NCT05426057
Recruiting
The goal of this study is to evaluate in an effectiveness-implementation type I hybrid trial, an enhanced version of eHealth Familias Unidas for reducing depressive, anxious symptoms and suicide behavior in Hispanic youth. The study will use a randomized rollout design with 18 pediatric primary care clinics in the South Florida area.
Gender:
All
Ages:
Between 12 years and 16 years
Trial Updated:
10/17/2023
Locations: Jessie Trice Community Health Center, Miami, Florida +15 locations
Conditions: Depression, Anxiety, Suicide, Drug Use
Register for Updates
An Open-Label Extension Study of GSK3511294 (Depemokimab) in Participants Who Were Previously Enrolled in 206713 (NCT04719832) or 213744 (NCT04718103)
NCT05243680
Recruiting
The purpose of this open-label 12-month extension study is to continue to characterize the long-term safety, efficacy and immunogenic profile of GSK3511294 (Depemokimab) in participants with severe asthma with an eosinophilic phenotype following completion of clinical studies 206713 or 213744.
Gender:
All
Ages:
12 years and above
Trial Updated:
10/13/2023
Locations: GSK Investigational Site, Miami, Florida +5 locations
Conditions: Asthma
Register for Updates
A Phase II Study of Nivolumab + Ipilimumab in Advanced HCC Patients Who Have Progressed on First Line Atezolizumab + Bevacizumab
NCT05199285
Recruiting
This phase II trial tests whether nivolumab and ipilimumab works to shrink tumors in patients with liver cancer that has spread to nearby tissue or lymph nodes (locally advanced), has spread to other places in the body (metastatic), or cannot be removed by surgery (unresectable). Immunotherapy with monoclonal antibodies, such as nivolumab and ipilimumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Nivolumab and ipilim... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
10/13/2023
Locations: University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami, Florida
Conditions: BCLC Stage B Hepatocellular Carcinoma, BCLC Stage C Hepatocellular Carcinoma, Locally Advanced Hepatocellular Carcinoma, Metastatic Hepatocellular Carcinoma, Stage III Hepatocellular Carcinoma AJCC v8, Stage IIIA Hepatocellular Carcinoma AJCC v8, Stage IIIB Hepatocellular Carcinoma AJCC v8, Stage IV Hepatocellular Carcinoma AJCC v8, Stage IVA Hepatocellular Carcinoma AJCC v8, Stage IVB Hepatocellular Carcinoma AJCC v8, Unresectable Hepatocellular Carcinoma
Register for Updates
A Study of Efficacy and Safety of Rosnilimab in Subjects With Moderate to Severe Rheumatoid Arthritis (RENOIR)
NCT06041269
Recruiting
RENOIR Study: This study will evaluate the safety, tolerability, and efficacy of Rosnilimab in subjects with moderate to severe Rheumatoid Arthritis (RA)
Gender:
All
Ages:
Between 18 years and 65 years
Trial Updated:
10/11/2023
Locations: AnaptysBio Investigative Site 10-102, Miami, Florida
Conditions: Rheumatoid Arthritis
Register for Updates
A Dose-Finding Study to Evaluate the Efficacy and Safety of GSK3858279 in Adults With Knee Osteoarthritis Pain
NCT05838742
Recruiting
This is dose-finding study of GSK3858279 in participants with moderate to severe knee osteoarthritis (OA) pain. The purpose of this study is to investigate and provide the data necessary to select the optimal effective and safe dose(s) of GSK3858279.
Gender:
All
Ages:
Between 40 years and 80 years
Trial Updated:
10/11/2023
Locations: GSK Investigational Site, Miami, Florida +1 locations
Conditions: Pain
Register for Updates
Immune Reconstitution in Stem Cell Transplant Recipients
NCT02129543
Recruiting
This specimen collection lab protocol will allow the investigators to prospectively study immune reconstitution in patients being treated for hematologic disorders and immune factors affecting graft versus host disease in stem-cell transplant (SCT) patients.
Gender:
All
Ages:
Between 18 years and 75 years
Trial Updated:
10/10/2023
Locations: University of Miami, Miami, Florida
Conditions: Cancer
Register for Updates
R&D Study to Evaluate Cordio's Usability and to Collect Patient Speech Utterances
NCT05876533
Recruiting
To determine the usability and technical aspects of Cordio HearO™
Gender:
All
Ages:
22 years and above
Trial Updated:
10/10/2023
Locations: C&R Research Services, Miami, Florida +1 locations
Conditions: Chronic Heart Failure
Register for Updates
A Study of NCS-01 in Patients With Acute Ischemic Stroke
NCT03915431
Recruiting
This is an initial Phase1/2 dose-finding, randomized, multi-center study to evaluate the safety and tolerability of NCS-01 in patients with acute ischemic stroke. All patients will be randomized within 48 hours of stroke onset. This study will be conducted in 2 stages.
Gender:
All
Ages:
Between 18 years and 85 years
Trial Updated:
10/09/2023
Locations: University of Miami, Miami, Florida
Conditions: Ischemic Stroke
Register for Updates
Saroglitazar Magnesium 4 mg in the Treatment of NAFLD in Women With PCOS (EVIDENCES VII)
NCT03617263
Recruiting
This is a multicenter, phase 2A, randomized, double-blind, placebo-controlled study designed to evaluate the efficacy and safety of Saroglitazar Magnesium in women with well characterized PCOS.
Gender:
Female
Ages:
Between 18 years and 45 years
Trial Updated:
10/06/2023
Locations: Dr. Yaneicy Gonzalez Rojas, Miami, Florida
Conditions: Non-alcoholic Fatty Liver Disease in Women With PCOS
Register for Updates